AskTheDate.com
Back to calendar

Maze Therapeutics, Inc. (MAZE) Earnings

MAZE reports earnings on Tuesday, August 18, 2026

earnings report
August 18, 2026 · Before Market Open
Q2 2026
Est. EPS: $-0.72
Actual EPS: $-0.45
EPS surprise: 21.98%
Company overview
Market Cap$1.5B
PriceUSD 27.10
EPS (TTM)-2.54
52-week high53.65
52-week low12.81
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees141